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S U M M A R Y
Objectives: The objectives of this study were to identify the risk factors for measles and low vaccination
rates, to evaluate the performance of surveillance, and to calculate vaccine effectiveness and failure in
Iraq for the years 2005 to 2010.
Methods: Logistic regression was used on measles surveillance data from Iraq obtained during the period
1 January 2005 to 31 December 2010; adjusted odds ratios were calculated. The performance of
surveillance was evaluated according to World Health Organization (WHO) guidelines.
Results: Of 18 746 suspected cases, a measles diagnosis was made for 81.4%. Children aged 1–5 years
were the most affected (>48%). The odds of measles were signiﬁcantly higher in the central and southern
provinces than in the northern provinces. Those vaccinated with at least one dose of measles-containing
vaccine had a 3.7-times lower risk of contracting measles than those who were not vaccinated. Lower
odds of vaccination were noted for adults aged 18 years and older and those living in central and
southern provinces, as well as those living outside the capital city of a province. Three WHO performance
indicators were lower than the recommended cut-off levels. A vaccine failure rate of 66.1% and
effectiveness of 90.03% were estimated.
Conclusions: Measles continues to be an important cause of morbidity in Iraq. Improvements in vaccine
coverage, proper vaccine handling, and prompt reporting of suspected cases are all necessary to
eliminate measles from Iraq.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Measles is an important vaccine-preventable cause of infectious
disease morbidity and mortality in developing countries. Accord-
ing to the World Health Organization (WHO), measles killed
164 000 people in 2008, with approximately 450 deaths every day
and 18 deaths every hour.1 With the continued occurrence of
measles outbreaks in the Eastern Mediterranean Region (EMR)
during 2009–2011, the measles elimination target of 2010 for this
region has been postponed to 2015.2 However, global measles
mortality at all ages decreased by 78% between 2000 and 2008,
with the largest percentage reduction being in the EMR, where
measles mortality decreased by 93%.3
More than 1.3 million cases of measles have been reported from
Iraq over the last 50 years, with an annual average of 25 114 cases,
750–1250 deaths, and a case fatality rate of 3–5%. However,* Corresponding author. Tel.: +1 402 218 0300; fax: +1 402 552 3683.
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in Iraq in the early 1980s reduced the average number of measles
cases from 39 000 to 9400 annually. In 1997, the EMR Ofﬁce
(EMRO) Regional Committee set the measles elimination target to
‘‘eliminate measles virus transmission’’ in the EMR by 2010.4
Although Iraq adopted measles elimination strategies in 2004, at
least two major outbreaks occurred in the country during 2008 and
2009, as the number of cases observed was greater than the
expected number compared to the previous years.4,5
According to the Iraqi routine immunization schedule, each
child should receive two doses of measles-containing vaccine
(MCV) by the age of 15 months, the ﬁrst dose being given at 9
months of age, followed by a second dose given at least 1 month
later. Lowering the age at ﬁrst dose of vaccination to 6 months is
considered when measles outbreaks occur that heavily target the
younger age groups. The measles–mumps–rubella (MMR) vaccine
is the preferred MCV in Iraq.4
Adequate vaccine coverage is key to achieving the herd
immunity level required to prevent measles outbreaks by
decreasing the population density of susceptible individuals.6ses. Published by Elsevier Ltd. All rights reserved.
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suggest a range of 90–95% herd immunity in order to terminate the
transmission of measles in the population.7 The EMRO requires at
least 95% coverage annually with both MCV1 and MCV2 to be
achieved and maintained in all districts or their administrative
equivalent and at the national level.8 In populations with low
vaccination coverage, epidemics occur regularly every 2 or 3
years.6 Unfortunately, the vaccine coverage rate in Iraq decreased
dramatically from 87% in 2000 to 69% in 2009.9
Another key strategy for reducing measles mortality is enhancing
measles surveillance, with integration of epidemiological and
laboratory information aimed at providing the necessary sensitivity
and speciﬁcity for detecting measles virus.4,10 Being among the
countries with an elimination goal, effective surveillance systems
are necessary in Iraq at the district, provincial, and country levels.8
Unfortunately, little is known about the dynamics and
epidemiology of measles outbreaks and the measles surveillance
system in Iraq. The current study provides an analysis of measles
surveillance data collected during 2005–2010 for identifying the
risk factors of measles in Iraq, determining factors associated with
lower vaccination rates against measles, evaluating the perfor-
mance of the measles surveillance system, and calculating vaccine
effectiveness and failure in the country.
2. Materials and methods
The reporting of all suspected measles cases from the primary
health centers, private clinics, and hospitals to the Preventive
Health Department (PHD) in the Directorate General of Health
(DGoH) of each province is mandatory. Notiﬁcations are done via
mailing of the standard communicable notiﬁcation forms designed
by the Ministry of Health (MOH), to the Communicable Disease
Control Unit (CDCU) of the regional PHD. Less commonly, the care-
providing physician will notify suspected measles cases by
telephone call to the health inspectors in the CDCU. Case-based
epidemiological surveillance is subsequently conducted by the
CDCU for investigating the notiﬁed cases.4 Measles surveillance
data from Iraq during the period 1 January 2005 to 31 December
2010 were used in the current study.
In accordance with the WHO recommendations, a single serum
sample was collected from the suspected cases at the time of their
ﬁrst contact with a health facility, and sent to the Central
Laboratory in Baghdad for the detection of measles-speciﬁc IgM
using standardized, validated, and rapid ELISA IgM assays.2
However, laboratory investigation was not done for all suspected
cases during the outbreaks, as the WHO recommends laboratory
testing of only 5–10 cases per outbreak while classifying the
disease status of the remaining cases on an epidemiological basis.5
The notiﬁed measles cases were conﬁrmed or ‘discarded’
according to the WHO standard case deﬁnition guidelines.10 A
suspected or clinically diagnosed case was deﬁned as any person in
whom a clinician suspected measles infection or any person with
fever and a maculopapular rash, and one or more of the following:
cough, coryza, and conjunctivitis, occurring between 1 January 2005
and 31 December 2010 at any location within Iraq. A laboratory
conﬁrmed case was deﬁned as a case meeting the clinical case
deﬁnition and conﬁrmed by the presence of measles-speciﬁc IgM
antibodies. An epidemiological case was deﬁned as a case meeting
the clinical case deﬁnition and linked epidemiologically to a
laboratory conﬁrmed case. Epidemiological linkage means direct
contact with another laboratory conﬁrmed measles case with rash
onset occurring 7–18 days before the present case. A suspected case
was discarded if it did not meet the clinical or laboratory deﬁnitions.
Surveillance data investigated in this study were patient age,
province of residence, household location within or outside the
capital city of the province, gender, vaccination status, date ofonset of rash, date of specimen collection, date the specimen was
sent to the Central Laboratory in Baghdad, date of investigation,
date of notiﬁcation to the DGoH, date the sample was received by
the Central Laboratory in Baghdad, and date on which the results
were reported. The vaccination status of the cases was determined
by relative or patient verbal report and/or by reviewing the
patient’s immunization card.
For descriptive study purposes, Iraq was divided into three
main regions: (1) the northern region, which is the semi-
autonomous Kurdistan region controlled by the Kurdistan Regional
Government (KRG) since 1991; this includes the provinces of Erbil,
Sulaymaniyah, and Duhok; (2) the central region, including the
provinces of Nienawa, Kirkuk, Diyala, Salah Al-Din, Baghdad, and
Anbar; and (3) the southern region, including the provinces of
Babylon, Kerbala, Najaf, Wassit, Diwanya, Missan, Muthanna, Thi-
Qar, and Basrah. These regions have different geo-demographic,
ethnic, and religious characteristics, and such a division has
already been adopted by United Nations organizations, including
the United Nations High Commissioner for Refugees (UNHCR).11
All surveillance data were entered into Microsoft Excel 2010
(Genuine Microsoft Ofﬁce Software, Louisville, KY, USA) and
analyzed using SPSS 18 for Windows/MAC (PASW1 Statistics
GradPack 18). A set of multivariate binary logistic regression
models was generated to calculate the adjusted odds ratios (OR)
along with 95% conﬁdence intervals (CI) for the outcomes of being
vaccinated with at least one dose of MCV and having a conﬁrmed
diagnosis of measles separately, for the different variables
investigated in the study. The tests were two-sided, and the
signiﬁcance level was set at 0.05.
3. Results
A total of 18 746 cases of suspected measles were notiﬁed in Iraq
from 1 January 2005 to 31 December 2010. Of these, 15 254 cases
were diagnosed as conﬁrmed measles on a laboratory (n = 8800),
epidemiological (n = 6304), or clinical (n = 150) basis. Figure 1 shows
the distribution of cases by month for the 6-year study period.
Table 1 shows the suspected and conﬁrmed measles cases by
region of residence, household location within the region, sex, and
age group. All notiﬁed cases were of Iraqi nationality and,
fortunately, no measles-related deaths or serious complications
(e.g., blindness, encephalomyelitis, or pneumonia) were reported.
Suspected cases varied widely in age from 2 days to 82 years,
with a median age of 2 years. The age of conﬁrmed cases ranged
from 1 month to 82 years, with a median of 3 years. The
distribution of conﬁrmed and discarded cases by different age
groups is shown in Figure 2.
A total of 3376 (18.0%) suspected cases were found to have been
vaccinated with at least one dose of MCV; 12 878 (68.7%) had not
been vaccinated and 2492 (13.3%) had an unknown vaccination
history. The majority of those with an unknown vaccination
history were among the cases reported from the southern
provinces (53.7%) and those living outside the capital city of the
province (56.5%), with a slightly higher proportion of males
(51.6%). Table 2 shows the vaccination status of notiﬁed measles
cases with a known vaccination history (n = 16 254) and the
association of vaccination status with certain demographic
characteristics. The original model contained region of residence,
household location within the province, sex, and age as covariates.
After adjusting for the effects of province of residence, household
location, and gender, the ﬁnal multivariate logistic regression model
showed that younger children (8 months–5 years) were signiﬁcantly
more likely to have been vaccinated with at least one dose of MCV
than individuals aged 13–17 years (adjusted OR (AOR) 0.64, 95% CI
0.52–0.78). The odds of vaccination were signiﬁcantly lower in both
the central and southern provinces compared to the northern
Figure 1. Suspected (n = 18 746) and conﬁrmed (n = 15 254) measles by month,
Iraq, 2005–2010.
Figure 2. Conﬁrmed (n = 15 254, green bars) and discarded (n = 3492, blue bars)
measles cases by age group, Iraq, 2005–2010. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of the article.)
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0.12, 95% CI 0.08–0.18, respectively). Signiﬁcantly higher odds of
vaccination were noted from the central provinces compared to the
southern ones (AOR 1.55, 95% CI 1.41–1.69; not shown). Cases living
outside the capital city of the province were 10% less likely to be
vaccinated (AOR 0.90, 95% CI 0.82–0.99).
Table 3 shows the AOR for ‘conﬁrmed’ measles status of the
suspected cases in association with certain predictor variables. The
multivariate logistic regression model contained region of resi-
dence, household location within the province, sex, age, and
vaccination status.
The ﬁnal model showed that individuals vaccinated with at
least one dose of MCV were at 3.7-times lower risk of being
infected with measles than those in the non-vaccinated groupTable 1
Suspected and conﬁrmed measles cases by certain characteristics, Iraq, 2005–2010
Characteristics Notiﬁed
cases (%)
(n = 18 746)
Conﬁrmed
cases (%)
(n = 15 254)
Region
Northern Iraq (Kurdistan region) 316 (1.7) 111 (0.7)
Central Iraq 8793 (46.9) 7207 (47.2)
Southern Iraq 9637 (51.4) 7936 (52.0)
Household location
Within the capital of the province 7138 (38.1) 5792 (38.0)
Outside the capital of the province 11 608 (61.9) 9462 (62.0)
Sex
Male 9869 (52.6) 8046 (52.7)
Female 8877 (47.4) 7208 (47.3)
Vaccination history
At least one dose of MCV 3376 (18.0) 2307 (15.1)
No vaccination 12 878 (68.7) 11 231 (73.6)
Unknown 2492 (13.3) 1716 (11.2)
MCV, measles-containing vaccine.(AOR 0.27, 95% CI 0.25–0.30). The analysis also revealed that the
odds of a measles diagnosis were signiﬁcantly higher in the central
(AOR 6.39, 95% CI 4.84–8.44) and southern provinces (AOR 5.71,
95% CI 4.31–7.58) compared to the northern ones. However, no
signiﬁcant difference was found in the odds of a measles diagnosis
between the central and southern provinces (AOR 1.12, 95% CI 1.0–
1.22; not shown). Compared to those under the age of 1 year, all
age groups had a signiﬁcant positive association with the diagnosis
of measles, the highest odds being for the age group of 18 years and
older (AOR 4.45, 95% CI 3.74–5.28). Cases living outside the capital
city of the province were about 10% more likely to be affected with
measles (AOR 1.11, 95% CI 1.05–1.21). By far, the majority of cases
occurred in 2008 and 2009 (Figure 3).
Concerning the performance of the measles surveillance system
in Iraq during the study period, data analysis revealed that two of
the indicators exceeded the WHO-set cut-off level of 80% (Table 4).
Finally, we calculated a measles vaccine failure rate of 66.1%
and effectiveness of 90.03%.
The measles surveillance system in Iraq was evaluated by
comparing certain performance indicators set by the WHO to the
recommended cut-off level of 80%.10 These included percentage of
suspected measles cases notiﬁed 48 h after rash onset,
percentage of suspected cases investigated 48 h after notiﬁca-
tion, percentage of suspected cases with adequate specimen
collected within 28 days of rash onset, percentage of suspected
case serum/dried blood specimens that arrived at the Central
Laboratory within 7 days of collection, and percentage of results
reported within 7 days of receipt of the specimens. However, no
data on the percentage of weekly reports received by the PHD
were available.
The vaccine failure rate was calculated by estimating the
proportion of cases among the vaccinated population.6,12 Vaccine
effectiveness (VE) was measured using the formula PCV = PPV 
(PCV  VE)/1  (PCV  VE), where PCV is the proportion of cases
Table 2
Vaccination status of notiﬁed measles cases with known vaccine status (n = 16 254) and association with certain demographic characteristics, Iraq, 2005–2010
Characteristics Vaccination statusa Adjusted OR
Vaccinatedb (n = 3376) (%) Not vaccinated (n = 12 878) (%) p-Value OR 95% CI
Region
Northern Iraq (Kurdistan region) 113 (46.9) 128 (53.1) 1
Central Iraq 1844 (23.9) 5870 (76.1) <0.001 0.19 0.13–0.27
Southern Iraq 1419 (17.1) 6880 (82.9) <0.001 0.12 0.08–0.18
Household location
Within the capital of the province 1175 (19.4) 4880 (80.6) 1
Outside the capital of the province 2201 (21.6) 7998 (78.4) 0.026 0.90 0.82–0.99
Sex
Female 1626 (21.2) 6046 (78.8) 1
Male 1750 (20.4) 6832 (79.6) 0.52 0.97 0.89–1.06
Age group
8 months–5 years 2146 (28.6) 5359 (71.4) 1
6–12 years 589 (33.0) 1194 (67.0) <0.001 1.27 1.14–1.42
13–17 years 179 (18.0) 818 (82.0) <0.001 0.64 0.52–0.78
18 years 194 (8.8) 2013 (91.2) <0.001 0.29 0.26–0.34
OR, odds ratio; CI, conﬁdence interval; MCV, measles containing virus.
a At least one dose MCV.
b Reference category.
Table 3
Measles conﬁrmation status of notiﬁed cases (n = 18 746) and association with selected variables, Iraq, 2005–2010
Characteristics Measles status Adjusted OR
Conﬁrmed (%) Discarded (%)a p-Value OR 95% CI
Region
Northern Iraq (Kurdistan region) 111 (0.7) 205 (5.9) 1
Central Iraq 7207 (47.2) 1586 (45.4) <0.001 6.39 4.84–8.44
Southern Iraq 7936 (52.0) 1701 (48.7) <0.001 5.71 4.31–7.58
Household location
Within the capital of the province 5792 (38.0) 1346 (38.5) 1
Outside the capital of the province 9462 (62.0) 2146 (61.5) 0.031 1.11 1.05–1.21
Sex
Female 7208 (47.3) 1669 (47.8) 1
Male 8046 (52.7) 1823 (52.2) 0.15 1.07 0.98–1.16
Age group (years)
<1 2856 (18.7) 1003 (28.7) 1
1–5 7426 (48.7) 1643 (47.1) <0.001 2.40 2.16–2.67
6–12 1790 (11.7) 517 (14.8) <0.001 1.86 1.60–2.15
13–17 821 (5.4) 108 (3.1) <0.001 3.37 2.58–4.40
18 2361 (13.8) 221 (6.3) <0.001 4.45 3.74–5.28
Vaccination statusb
Non-vaccinated 11 231 (73.6) 1647 (47.2) 1
Vaccinated 2307 (15.1) 1069 (30.6) <0.001 0.27 0.25–0.30
Unknown 1716 (11.2) 776 (22.2) <0.001 0.28 0.24–0.29
OR, odds ratio; CI, conﬁdence interval; MCV, measles-containing vaccine.
a Reference category.
b Vaccinated with at least one dose of MCV.
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vaccinated, and VE is the vaccine effectiveness.5
Those with an unknown vaccination history and those under
the age of 8 months (the minimum age for routine vaccination) and
over 12 years were excluded from these calculations. The latter
group was excluded because older persons tended to have
inadequate and unreliable immunization documentation, as well
as the possibility of having natural active immunity from a
previous infection.13 PPV is derived from the average vaccine
coverage rate in Iraq reported by the United Nations Children’s
Fund (UNICEF) from 1993 (the estimated birth year for a 12-year-
old case reported in 2005) to 2009 (the last year of reported vaccine
coverage rate).14
4. Discussion
Measles continues to be a signiﬁcant cause of infectious
morbidity in Iraq. Measles cases tend to cluster during winter andspring, whereas they decrease towards the end of summer
(Figure 1). This is the typical seasonality of measles outbreaks in
temperate climates. These outbreaks are likely the result of the
congregation of children at school, gathering of people at home and
work places during the cold weather, and favorable environmental
factors for viral transmission.6,12
The low vaccination odds in the older age groups (Table 2) can
be explained by the fact that the majority of them were born before
the adoption of the EPI in Iraq in the early 1980s or during the early
years of routine measles vaccination when coverage rates were
characteristically low.14 On the other hand, the higher odds of
vaccination among those aged 6–12 years coincides with the
average coverage rate of 85% from 1995 to 2002.14 The ﬁnding of
signiﬁcantly higher vaccination odds in the Kurdistan region of
Iraq compared to both the central and southern provinces is
consistent with previous ﬁndings of relatively higher measles
immunization coverage rates in this region and better capacity of
its EPI in reaching children under 1 year of age.15 This can be
Figure 3. Conﬁrmed measles cases by year, Iraq, 2005–2010.
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Kurdistan region compared to the rest of Iraq.16
As expected, individuals vaccinated with at least one-dose of
MCV were at 3.7-times lower risk of contracting measles (Table 3).
The analysis also revealed that cases living outside the capital city
of the province were about 10% more likely to be affected with
measles. This seemingly paradoxical ﬁnding to the common notion
of higher measles rates in urban areas6 corresponds to our ﬁnding
of 10% lower vaccination outside the capital city of the province
(Table 2). No statistically signiﬁcant association was found
between measles and household location in another recent
outbreak of measles from Tabuk, Saudi Arabia.12
The ﬁnding that the majority of measles cases occurred among
children in the age group 1–5 years (Figure 2) is expected in
communities with relatively low vaccine coverage.6 However, the
ORs of measles were signiﬁcantly higher for the older age groups
(Table 3). This is most likely due to the signiﬁcantly high number of
notiﬁed suspected cases for the age group 1–5 years: 9069
accounting for 48.4% of the total notiﬁed cases, of which 7426 cases
were conﬁrmed (48.7% of total conﬁrmed cases) and 1643 were
discarded (47.1% of total discarded cases). Despite the difﬁculties
in obtaining accurate demographic ﬁgures in Iraq, a rough estimate
of the relative risk of measles in the under-5 years age group
compared to those aged 18 years and older was signiﬁcantly higher
(RR 13.2). Thus, a selection bias had most probably occurred as the
clinicians were more readily reporting suspected cases in the
younger age groups. Another remarkable ﬁnding in our study was
that 18.7% of the conﬁrmed cases were found among those under 1
year of age; this shows the necessity of adequate vaccine coverage
for this age group.Table 4
Evaluation of measles surveillance system performance by certain WHO recommended
Surveillance performance indicators 
Suspected measles cases notiﬁed 48 h after rash onset 
Suspected measles cases investigated 48 h after notiﬁcation 
Suspected measles cases with adequate specimen collected within 28 days of rash o
Suspected measles cases with specimens received by the laboratory within 7 days o
Suspected measles cases with laboratory result reported within 7 days There were dramatically increased numbers of conﬁrmed
measles cases in 2008 and 2009 compared to 2005 (Figure 3). A
number of factors can explain this phenomenon, including the low
vaccine coverage rates and high vaccine failure rate. The observed
measles vaccine failure rate for Iraq was exceptionally high
(66.1%), although it was lower than the failure rates observed
during recent outbreaks in Riyadh, Saudi Arabia (90%).17 In general,
primary vaccine failure occurs in approximately 15% of children
vaccinated at 9 months of age and 5–10% of children vaccinated at
1 year of age. The vaccine failure rate is increased by factors such as
inappropriate vaccine handling, failure of cold-chain maintenance,
improper administrative procedures, and probably other host- and
vaccine-related factors.18 However, vaccine effectiveness was
90.03%, representing the proportion of vaccinated children in
the entire population who developed protective immunity.6,19 It is
noteworthy that the proportion of cases in vaccinated children
increased as measles vaccine coverage increased, since a greater
proportion of cases occurred in children who did not respond to the
ﬁrst dose of MCV compared to those who were never vaccinated.
This phenomenon is sometimes misinterpreted as loss of vaccine
potency.6
However, failure to vaccinate susceptible persons remains an
important reason for not achieving adequate levels of herd
immunity. Low vaccine coverage rates can be due to insufﬁcient
resources, inaccessibility (dwellers of insecure regions, nomadic
persons, internally displaced families), lack of clear political will,
and the fear of real or perceived adverse events.6 With the 2009
coverage rate of 69%, a vaccine effectiveness of 90.05%, and 949 000
births,14 about 589 000 of the children are immune to measles
while the remainder, about 360 000, are susceptible (according to
the formula: number of births  vaccine coverage rate  vaccine
efﬁcacy).6
Despite the large proportion of the suspected cases being
reported within 48 h after rash onset (70.6%), this ﬁgure is still
below the target of 80% (Table 4). Delayed notiﬁcation is mostly
due to delays in seeking treatment and, sometimes, delayed
notiﬁcation by the health care providers. For 93.3% of notiﬁed
cases, blood samples were collected in a timely manner and sent to
the laboratory; however blood samples for 37.2% of cases were
received by the Central Laboratory in Baghdad at 7 days later.
This delay might be explained by the difﬁculty in transportation
between various regions of Iraq owing to the challenging security
situation in the country. Laboratory results of only 59.6% of cases
were reported within 7 days of receiving the sample, indicating a
delay in performing the test, mostly as a result of the heavy
workload and insufﬁcient staff numbers.
As far as we know, this study is the ﬁrst providing a detailed
analysis of the epidemiology of measles in Iraq. The population
covered by the study was large, including suspected cases from
different parts of the country over 6 consecutive years. The study
allowed for the analysis of different variables associated with
measles disease and vaccination, as well as the performance of the
measles surveillance system in the country and vaccine char-
acteristics.
This study was limited by the fact that the sources of the
outbreaks in 2008 and 2009 were unidentiﬁed and the vaccination indicators, Iraq, 2005–2010
Target per WHO (%) Achievement (%)
80 70.6
80 95.5
nset 80 93.3
f collection 80 62.8
80 59.6
J. Jasem et al. / International Journal of Infectious Diseases 16 (2012) e166–e171 e171status of several cases was assessed by proxy and/or patient recall,
which is subject to recall bias. Although the vaccination status for a
number of individuals was unknown, this is unlikely to signiﬁ-
cantly affect the study results, as the association between vaccine
status of suspected cases and the diagnosis of measles among them
was consistent with the common knowledge of the vaccine being
protective against measles. Unfortunately, no adequate data were
available for the second dosage of MCV. As the discarded cases may
not be representative of the whole population, the odds presented
in this study may reﬂect the odds of ‘disease conﬁrmation’ for the
notiﬁed cases.
The continuous incidence of measles outbreaks in Iraq indicates
that more efforts are needed in order to eliminate measles from the
country. Expanding vaccine coverage, increasing population
awareness about the beneﬁts of vaccination, emphasizing the
necessity of immediate case notiﬁcation and result reporting
among health care and laboratory workers, conducting future
serological studies to identify the immunological status of
vaccinated people and the reasons for vaccine failure, and using
molecular epidemiology to identify the strains of wild measles
virus circulating during the outbreaks are all essential factors for
eradicating measles from Iraq.
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